← FDA Drug Approvals (Drugs@FDA)
TOFACITINIB CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2024-06-03
Drug application
- FDA Application #
ANDA218462- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TOFACITINIB CITRATE
- Generic name
- TOFACITINIB
- Active ingredients
- TOFACITINIB CITRATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2024-06-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown